OverviewChartNewsTraderScreen

22nd Century Group Inc/  US90137F3010  /

IEX
20/09/2024  21:54:39 Chg. 0.00 Volume Bid- Ask- High Low
0.27USD +1.84% 2,261
Turnover: 601.49		 -Bid Size: - -Ask Size: - 0.28 0.25
GlobeNewswire 21/08 Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now
GlobeNewswire 20/08 Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
GlobeNewswire 17/07 Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
GlobeNewswire 16/07 Presenting on the Emerging Growth Conference 73 Day 1 on July 17 Register Now
GlobeNewswire 06/02 Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now
GlobeNewswire 04/12/2023 22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
GlobeNewswire 29/11/2023 22nd Century Appoints Larry Firestone as Chairman and CEO
GlobeNewswire 27/11/2023 22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
GlobeNewswire 08/11/2023 22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
GlobeNewswire 07/11/2023 22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
GlobeNewswire 06/11/2023 22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
GlobeNewswire 26/10/2023 22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
GlobeNewswire 25/10/2023 22nd Century Group (XXII) Reduces Debt by $8.1 Million
GlobeNewswire 17/10/2023 22nd Century Announces Pricing of $5.25 Million Public Offering
GlobeNewswire 16/10/2023 22nd Century Announces Proposed Public Offering
GlobeNewswire 12/09/2023 22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
GlobeNewswire 05/09/2023 22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
GlobeNewswire 05/09/2023 Presenting on the Emerging Growth Conference on September 6 and 7 Register Now
GlobeNewswire 28/03/2022 FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smo...
GlobeNewswire 09/03/2022 22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
GlobeNewswire 28/02/2022 22nd Century Group Announces South Korea as First VLN® International Market
GlobeNewswire 25/02/2022 22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in ...
GlobeNewswire 10/02/2022 22nd Century Secures USDA Organic Certification for Needle Rock Farms
GlobeNewswire 03/02/2022 22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
GlobeNewswire 26/01/2022 22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale